- Full Year 2023 Smith & Nephew PLC Earnings Call TranscriptFeb 27, 2024R$28.68Earnings
- Smith & Nephew PLC Meet the Management Event TranscriptNov 29, 2023
- Q3 2023 Smith & Nephew PLC Trading Statement Call TranscriptNov 02, 2023
- Half Year 2023 Smith & Nephew PLC Earnings Call TranscriptAug 03, 2023R$30.4Earnings
- Q1 2023 Smith & Nephew PLC Trading Statement Call TranscriptApr 26, 2023
- Full Year 2022 Smith & Nephew PLC Earnings Call TranscriptFeb 21, 2023R$28.8Earnings
- Q3 2022 Smith & Nephew PLC Trading Statement Call TranscriptNov 03, 2022
- Half Year 2022 Smith & Nephew PLC Earnings Call TranscriptJul 28, 2022R$31.17Earnings
- Q1 2022 Smith & Nephew PLC Trading Statement Call TranscriptApr 28, 2022
- Full Year 2021 Smith & Nephew PLC Earnings Call TranscriptFeb 22, 2022R$33.72 (+0.51%)Earnings
- Smith & Nephew PLC Meet the Management Event TranscriptDec 16, 2021
- Q3 2021 Smith & Nephew PLC Trading Statement Call TranscriptNov 04, 2021
- Half Year 2021 Smith & Nephew PLC Earnings Call TranscriptJul 29, 2021R$44.69Earnings
- Q1 2021 Smith & Nephew PLC Trading Statement Call TranscriptApr 29, 2021
- Full Year 2020 Smith & Nephew PLC Earnings Call TranscriptFeb 18, 2021R$46.64Earnings
- Q3 2020 Smith & Nephew PLC Trading Statement Call TranscriptOct 29, 2020
- Smith & Nephew PLC Innovation in Focus - Virtual Investor Event TranscriptSep 08, 2020
- Half Year 2020 Smith & Nephew PLC Earnings and Q2 2020 Trading Statement Call TranscriptJul 29, 2020
- Q1 2020 Smith & Nephew PLC Trading Statement Call TranscriptMay 06, 2020
- Full Year 2019 Smith & Nephew PLC Earnings Call TranscriptFeb 20, 2020Earnings
- Q3 2019 Smith & Nephew PLC Trading Statement Call TranscriptOct 31, 2019
- Q2 2019 Smith & Nephew PLC Earnings Call TranscriptJul 31, 2019Earnings
- Q1 2019 Smith & Nephew PLC Trading Statement Call TranscriptMay 02, 2019
- Smith & Nephew PLC to Acquire Osiris Therapeutics Inc Call TranscriptMar 12, 2019
Q2 2019 Smith & Nephew PLC Earnings Call Transcript
Good morning, and welcome to Smith+ Nephew's First Half 2019 Results Presentation. I'm joined by Graham Baker, Chief Financial Officer; Simon Fraser, President of Advanced Wound Management; and Phil Cowdy.
I'll start by sharing the highlights of our half year numbers, with 3.9% underlying growth and improved trading profit margin of 21.4%. Then Simon will give you an update on our Wound business globally, and in particular, on our acquisition of Osiris. Third, Graham will provide details of our updated guidance for the full year.
So firstly, our results for the first half of 2019. We finished the half with revenue of $2.5 billion. That's 3.9% underlying growth and 1.8% reported. Growth at constant exchange rates and including the benefit of acquisitions was 6%. Our trading profit margin of 21.4% was 60 basis points higher than in the first half of last year, and adjusted earnings per share of $0.46 grew faster than revenue at plus 5%.
Smith+ Nephew is delivering on its commitment to accelerate our revenue
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)